Clinical Trials
6 trialsNCT06487858 2026-05-11
A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors
BeOne Medicines
Phase 1 Terminated
NCT06094426 2026-04-29
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors
Grit Biotechnology
Phase EARLY_PHASE1 Terminated
NCT05430360 2026-04-27
GT201
Grit Biotechnology
Phase 1 Terminated
NCT05729399 2026-04-27
Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors
Grit Biotechnology
Phase 1/2 Terminated
NCT05262530 2026-04-08
Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors
BioNTech SE
Phase 1/2 Terminated
NCT05023655 2026-03-17
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
Prisma Health-Upstate
Phase 2 Terminated